TFM
BIO icon

TFC Financial Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

TFC Financial Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279 Hold
1
– – ﹤0.01% 762
2025
Q4 		$303 Hold
1
– – ﹤0.01% 738
2025
Q3 		$281 Hold
1
– – ﹤0.01% 763
2025
Q2 		$242 Buy
+1
New +$236 ﹤0.01% 755
2024
Q4 		– Sell
-3
Closed -$1K – 983
2024
Q3 		$1K Buy
+3
New +$953 ﹤0.01% 589
2024
Q2 		– Sell
-3
Closed -$1.04K – 985
2024
Q1 		$1.04K Buy
3
+2
+200% +$658 ﹤0.01% 548
2023
Q4 		$323 Sell
1
-6
-86% -$1.88K ﹤0.01% 642
2023
Q3 		$2.51K Hold
7
– – ﹤0.01% 440
2023
Q2 		$2.65K Buy
+7
New +$2.85K ﹤0.01% 420

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return